JP Morgan Maintains Neutral on Sotera Health, Raises Price Target to $18

Benzinga Newsdesk www.benzinga.com Positive 64.1%

Neg 0% Neu 0% Pos 64.1%

JP Morgan analyst Casey Woodring maintains Sotera Health (NASDAQ:SHC) with a Neutral and raises the price target from $16 to $18.